VOLUME 9 (2018)
View Archive »
About The Cover
The cover for issue 78 of Oncotarget features Figure 4, "Effect of FKBP51 KO on glucocorticoid response and Akt/mTOR in HaCaT human keratinocytes," by Baida, et al.
|
|
Table of Contents
Editorial
|
| Influence of Scribble polarity complex on hematopoiesis and leukemia – a matter of where when and how |
|
https://doi.org/10.18632/oncotarget.26132
|
| 34642-34643 |
Research Papers
|
| Circulating cellfree miR494 and miR21 are disease response biomarkers associated with interimpositron emission tomography response in patients with diffuse large Bcell lymphoma |
|
https://doi.org/10.18632/oncotarget.26141
|
| 34644-34657 |
|
| The anticancer effect of retinoic acid signaling in CRC occurs via decreased growth of ALDH+ colon cancer stem cells and increased differentiation of stem cells |
|
https://doi.org/10.18632/oncotarget.26157
|
| 34658-34669 |
|
| The transgenic expression of the βsubunit of human chorionic gonadotropin influences the growth of implanted tumor cells |
|
https://doi.org/10.18632/oncotarget.26158
|
| 34670-34680 |
|
| ATR suppresses the protumorigenic functions of breast stromal fibroblasts |
|
https://doi.org/10.18632/oncotarget.26159
|
| 34681-34690 |
|
| Obesity and Alzheimer’s disease does the obesity paradox really exist A magnetic resonance imaging study |
|
https://doi.org/10.18632/oncotarget.26162
|
| 34691-34698 |
|
| βamyloid wall deposit of temporal artery in subjects with spontaneous intracerebral haemorrhage |
|
https://doi.org/10.18632/oncotarget.26165
|
| 34699-34707 |
|
| DDB2 regulates EpithelialtoMesenchymal Transition EMT in Oral/Head and Neck Squamous Cell Carcinoma |
|
https://doi.org/10.18632/oncotarget.26168
|
| 34708-34718 |
|
| H19 long noncoding RNA contributes to sphere formation and invasion through regulation of CD24 and integrin expression in pancreatic cancer cells |
|
https://doi.org/10.18632/oncotarget.26176
|
| 34719-34734 |
|
| Modelling ponatinib resistance in tyrosine kinase inhibitornaïve and dasatinib resistant BCRABL1+ cell lines |
|
https://doi.org/10.18632/oncotarget.26187
|
| 34735-34747 |
|
| Leukemia inhibitory factor via the Tolllike receptor 5 signaling pathway involves aggravation of cachexia induced by human gastric cancerderived 85As2 cells in rats |
|
https://doi.org/10.18632/oncotarget.26190
|
| 34748-34764 |
|
| Does afatinib plus bevacizumab combination therapy induce positive conversion of T790M in previouslynegative patients |
|
https://doi.org/10.18632/oncotarget.26192
|
| 34765-34771 |
|
| Deletion of the glucocorticoid receptor chaperone FKBP51 prevents glucocorticoidinduced skin atrophy |
|
https://doi.org/10.18632/oncotarget.26194
|
| 34772-34783 |
|
| Clinical impact of serum soluble SLAMF7 in multiple myeloma |
|
https://doi.org/10.18632/oncotarget.26196
|
| 34784-34793 |
|
| Multiomic based molecular profiling of advanced cancer identifies treatable targets and improves survival in individual patients |
|
https://doi.org/10.18632/oncotarget.26198
|
| 34794-34809 |
|
| Peritoneal NK cells are responsive to IL15 and percentages are correlated with outcome in advanced ovarian cancer patients |
|
https://doi.org/10.18632/oncotarget.26199
|
| 34810-34820 |
|
| PARP1 is required for preserving telomeric integrity but is dispensable for ANHEJ |
|
https://doi.org/10.18632/oncotarget.26201
|
| 34821-34837 |
|
| Extracellular vesicles in oral squamous carcinoma carry oncogenic miRNA profile and reprogram monocytes via NFκB pathway |
|
https://doi.org/10.18632/oncotarget.26208
|
| 34838-34854 |
Errata
|
| Erratum: Targeting Metabolic Remodeling in Glioblastoma Multiforme |
|
https://doi.org/10.18632/oncotarget.26219
|
| 34855-34855 |
|
| Erratum: Drug Discovery Approaches to Target Wnt Signaling in Cancer Stem Cells |
|
https://doi.org/10.18632/oncotarget.26220
|
| 34856-34856 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
